Islet β-cell function preservation by different anti-diabetic treatments in Chinese elderly patients with type 2 diabetes mellitus

Figure 1 Levels of blood glucose, insulin and C-peptide during oral glucose tolerance test at baseline (solid line) and followed-up (dash line) between different anti-diabetic treatment groups. A-C: Blood glucose; D-F: Plasma insulin; G-I: Plasma C-peptide; Data are mean ± SE. ^aP < 0.05. OCTT: Oral glucose tolerance test; OAD: Oral anti-diabetic drugs.

Figure 2 Percent of delayed inulin secretion response between baseline and followed-up after different anti-diabetic treatments. Ins: Insulin therapy; OAD: Oral anti-diabetic drugs.